INTEGRATED BIOPHARMA INC Deferred Federal, State and Local, Tax Expense (Benefit)
INTEGRATED BIOPHARMA INC (INBP) reported Deferred Federal, State and Local, Tax Expense (Benefit) of $55.00 thousand for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-15.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2023-09-15
- INTEGRATED BIOPHARMA INC deferred federal, state and local, tax expense (benefit) for fiscal 2023 was $55.00K, a 97.39% decline from fiscal 2022.
- INTEGRATED BIOPHARMA INC deferred federal, state and local, tax expense (benefit) for fiscal 2022 was $2.11M.
- INTEGRATED BIOPHARMA INC deferred federal, state and local, tax expense (benefit) for fiscal 2021 was -$1.19M, a 316.76% decline from fiscal 2020.
- INTEGRATED BIOPHARMA INC deferred federal, state and local, tax expense (benefit) for fiscal 2020 was $549.00K, a 11.59% decline from fiscal 2019.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2023-06-30 | $55.00K 10-K · filed 2023-09-15 | |
| 2022-06-30 | $2.11M 10-K · filed 2023-09-15 | -$402.00K 10-K · filed 2022-09-13 |
| 2021-06-30 | -$1.19M 10-K · filed 2022-09-13 | $1.19M 10-K · filed 2021-09-02 |
| 2020-06-30 | $549.00K 10-K · filed 2021-09-02 | |
| 2019-06-30 | $621.00K 10-K · filed 2020-09-23 | |
| 2018-06-30 | $430.00K 10-K · filed 2019-08-29 | |
| 2017-06-30 | $495.00K 10-K · filed 2018-09-12 | |
| 2016-06-30 | $114.00K 10-K · filed 2017-09-01 |